The mission of CBR Pharma Insights is to empower companies within the pharmaceutical industry to make the best business decisions possible through providing them with quality, innovative, strategic market research solutions.
CBR's market research solutions are focused on being both proactive & reactive in identifying, evaluating, and assessing the key strategic R&D; and commercial issues within the pharmaceutical industry.
A Global Hyperhidrosis Market Landscape Assessment: Trends, Forecasts and Opportunities in a Growing Market
GBI Research’s latest report, ""A Global Hyperhidrosis Market Landscape Assessment: Trends, Forecasts and Opportunities in a Growing Market"" provides an in-depth assessment of the current trends in the global hyperhidrosis market, with a particular focus on primary axillary hyperhidrosis
Pharmaceutical Deal Trends 2017 Factbook: Partnerships and Acquisitions Shift Focus Towards Early Stage Development, Emerging Markets, and Biologics
Although the pharmaceutical market is continuing to witness global growth, pharmaceutical and biotechnology companies are facing challenges due to disruptive events in the healthcare market, such as increasing costs of production and R&D, shifts in patent laws, and challenges in the economy. Companies are considering various strategies to overcome these challenges, with deal making being foremost among these as a means of boosting revenues over a short period of time
Read More »Mobile Health (mHealth) Technologies: Global Market Prospects - Featuring Expert Panel Views from Industry Survey 2017
GBI Research’s latest report Mobile Health (mHealth) Technologies: Global Market Prospects - Featuring Expert Panel Views from Industry Survey 2017 provides a comprehensive analysis of the mHealth landscape
Read More »Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline
GBI Research’s latest report, “Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline” is a comprehensive, granular analysis of the 25,522 products currently in the pharmaceutical industry pipeline, from the Discovery stage through to Pre-registration and split into therapy areas and key indications
Read More »Pharmaceutical Lifecycle Management Strategies in 2017
GBI Research’s latest report, ""Pharmaceutical Lifecycle Management Strategies in 2017"" provides a comprehensive assessment of product lifecycle (LCM) management strategies that are being implemented by pharmaceutical companies around the world
Read More »Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design
GBI Research’s latest report, ""Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design"" provides an in-depth assessment of the current trends in the global biosimilars market, with a particular focus on manufacturing complexities and the strategies being implemented to overcome them
Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing
GBI Research’s latest report,""Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing"" provides a comprehensive analysis of the changing pharmaceutical marketing landscape in the digital age
Big Data: Embracing Data to Transform Healthcare and Pharma Commercial Strategy - Featuring Expert Panel Views from Industry Survey 2016
GBI Research’s latest report,"" Big Data: Embracing Data to Transform Healthcare and Pharma Commercial Strategy - Featuring Expert Panel Views from Industry Survey 2016"" provides a comprehensive analysis of the Big Data landscape
Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during the Forecast Period
Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during the Forecast Period
Strategic Trends in Private Equity and Venture Capital Funding for Healthcare
GBI Research’s latest report, ""Strategic Trends in Private Equity and Venture Capital Funding for Healthcare"" provides a comprehensive analysis on emerging investment trends within the healthcare industry
The Future of Generic Drugs and Strategies for Commercial Success
GBI Research’s latest report “The Future of Generic Drugs and Strategies for Commercial Success” discusses trends in the global generic drugs market, and the evolving business strategies being adopted and leveraged by generic drug companies around the world.
Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D; Landscape
Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape
Read More »Innovation Tracking Factbook 2016 - An Assessment of the Pharmaceutical Pipeline
GBI Research’s latest report: “Innovation Tracking Factbook 2016: An Assessment of the Pharmaceutical Pipeline” is a comprehensive, granular analysis of the 20,756 products currently in the pharmaceutical industry pipeline, from the Discovery stage through to Pre-registration and split into therapy areas and key indications.
Read More »Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for Crossover Drugs
GBI Research's latest report, ""Human Drugs For Veterinary Use Current Trends and Future Commercial Prospects for Crossover Drugs"", discusses global commercial trends and prospects for human medicines applied in the veterinary setting, also called crossover drugs.
Read More »Substance Abuse Deterrents and Treatments - An Assessment of the Technological, Competitive and R&D; Landscape
GBI Research's latest report, "Substance Abuse Deterrents and Treatments - An Assessment of the Technological, Competitive and R&D Landscape", discusses global trends in the substance abuse deterrents and addiction treatments market including the impact substance abuse is having on local economies, healthcare systems and society as a whole.
Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies
GBI Research's latest report, ""Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies"", provides key insights into the global telehealth regulatory and market landscape, as well as its main applications in healthcare and associated sectors.
Read More »The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects
Over-the-counter (OTC) drugs are vital to treating a patient at home or a patient undertaking PoC (point-of-care).
Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future
GBI Research’s latest report, "Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future" discusses fundamental concepts in biobanking and recent technology advancements in the field.
Read More »Opioids Overview to 2021 - An Assessment of Pain Management and Dependence
GBI Research’s latest report, "Opioids Overview to 2021 - An Assessment of Pain Management and Dependence" discusses the use of opioids as potent analgesics for the treatment of cancer and non-cancer pain and examines the management of opioid dependence in the US, the UK, Germany, Spain, Italy, France, Australia, Japan, India and China.
Read More »BIOSIMILARS - Regulatory Framework and Pipeline Analysis
iosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared with innovative biologic products.
Read More »